1. Home
  2. MRVI vs HCKT Comparison

MRVI vs HCKT Comparison

Compare MRVI & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • HCKT
  • Stock Information
  • Founded
  • MRVI 2020
  • HCKT 1991
  • Country
  • MRVI United States
  • HCKT United States
  • Employees
  • MRVI N/A
  • HCKT N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • HCKT Professional Services
  • Sector
  • MRVI Health Care
  • HCKT Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • HCKT Nasdaq
  • Market Cap
  • MRVI 809.2M
  • HCKT 843.0M
  • IPO Year
  • MRVI 2020
  • HCKT 1998
  • Fundamental
  • Price
  • MRVI $4.77
  • HCKT $30.17
  • Analyst Decision
  • MRVI Buy
  • HCKT Strong Buy
  • Analyst Count
  • MRVI 10
  • HCKT 3
  • Target Price
  • MRVI $10.28
  • HCKT $30.00
  • AVG Volume (30 Days)
  • MRVI 1.8M
  • HCKT 78.4K
  • Earning Date
  • MRVI 02-25-2025
  • HCKT 02-18-2025
  • Dividend Yield
  • MRVI N/A
  • HCKT 1.09%
  • EPS Growth
  • MRVI N/A
  • HCKT N/A
  • EPS
  • MRVI N/A
  • HCKT 1.22
  • Revenue
  • MRVI $276,920,000.00
  • HCKT $300,739,000.00
  • Revenue This Year
  • MRVI N/A
  • HCKT $8.66
  • Revenue Next Year
  • MRVI $2.25
  • HCKT $5.16
  • P/E Ratio
  • MRVI N/A
  • HCKT $24.72
  • Revenue Growth
  • MRVI N/A
  • HCKT 4.09
  • 52 Week Low
  • MRVI $4.28
  • HCKT $20.23
  • 52 Week High
  • MRVI $11.56
  • HCKT $32.83
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 39.85
  • HCKT 48.48
  • Support Level
  • MRVI $4.38
  • HCKT $28.65
  • Resistance Level
  • MRVI $6.21
  • HCKT $31.00
  • Average True Range (ATR)
  • MRVI 0.39
  • HCKT 0.68
  • MACD
  • MRVI -0.09
  • HCKT -0.05
  • Stochastic Oscillator
  • MRVI 21.31
  • HCKT 61.79

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP-based executive advisory, strategic consulting, and digital transformation firm. It provides Generative Artificial Intelligence ("Gen AI") strategy, operations, finance, human capital management, strategic sourcing, procurement, and information technology. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

Share on Social Networks: